Resource Center

More to Explore - Information About Blood Cancers for Patients, Families and Healthcare Professionals

The Word:


February 26, 2013 - Blood Cancer Treatment - Making Informed Choices

Your order contains  item(s)  View Order

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: February 26, 2013
Time: 1:00 p.m. - 2:00 p.m. ET
Location: Telephone/Web
Read: Program Slides | Transcript
Listen: Presentation | Q&A Session
Access: Virtual Lecture

Topics Covered

  • Understanding goals of treatment for your diagnosis
  • Understanding your treatment options
  • Benefits and risks for standard treatments and investigational treatments
  • Key facts about clinical trials


Stephen D. Nimer, MD
Sylvester Comprehensive Cancer Center
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Miller School of Medicine
Miami, FL

Questions Asked by the Blood Cancer Community 

  • I was diagnosed with cytopenia (a reduction in the number of cells circulating in the blood). Do you recommend getting a bone marrow aspiration or biopsy? What about a second opinion?
  • With a diagnosis of relapsed chronic lymphocytic leukemia, is a stem cell transplant the next treatment step?
  • Why do some patients relapse and become resistant to treatment?
  • If lenalidomide (Revlimid®) is not working, can a patient switch to pomalidomide (Pomalyst®)?
  • Is being a bone marrow donor dangerous?
  • At what point does treatment start for a patient diagnosed with chronic lymphocytic leukemia?
  • Is whole genome sequencing done routinely? How can a patient get a personalized approach to treatment?

Sponsors and Supporters

This program is sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation and Millennium: The Takeda Oncology Company.

last updated on Thursday, September 11, 2014